The immunopharmaceutical effects and mechanisms of herb medicine

Cellular and Molecular Immunology

Volumn 5, Issue 1, 2008, Pages 23-31

  Huang, Chien Fu ^a   Lin, Shih Shen ^b   Liao, Pao Hsin ^b   Young, Su Chung ^c   Yang, Chi Chiang ^c  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

alternative medicine; autoimmune disease; herbal medicine; phytomedicine; T lymphocyte

Indexed keywords

ANTIOXIDANT; CYTOKINE; HERBACEOUS AGENT;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DRUG CONTRAINDICATION; DRUG EFFECT; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFECTION; MEDICINAL PLANT; METABOLISM; NEOPLASM; PHYTOTHERAPY; REVIEW; T LYMPHOCYTE;

ANTIBODY FORMATION; ANTIOXIDANTS; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; DRUGS, CHINESE HERBAL; HUMANS; IMMUNE SYSTEM; INFECTION; NEOPLASMS; PHYTOTHERAPY; PLANTS, MEDICINAL; T-LYMPHOCYTES;

EID: 47049109646     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.3     Document Type: Review

References (92)

1. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 1997; 40:598-609.
2. Panayi GS, Corrigall VM, Pitzalis C. Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin North Am. 2001;27:317-334. (Pubitemid 32488708)
3. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol. 1993;11:191-212. (Pubitemid 23115006)
4. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 1996;14:233-258. (Pubitemid 26130184)
5. Ho LJ, Chang DM, Lee TC, Chang ML, Lai JH. Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells. Eur J Pharmacol. 1999;367:389-398.
6. Hsieh C, Lin WC, Lee MR, et al. Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice. Immunopharmacol Immunotoxicol. 2003;25:259-271. (Pubitemid 36597421)
7. Asherson GL, Ferluga J, Janossy G. Non-specific cytotoxicity by T cells activated with plant mitogens in vitro and the requirement for plant agents during the killing reaction. Clin Exp Immunol. 1973;15:573-589.
8. Chandraker A, Azuma H, Nadeau K, et al. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest. 1998;101:2309-2318. (Pubitemid 28270425)
9. Lai JH, Ho LJ, Kwan CY, Chang DM, Lee TC. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation. 1999;68:1383-1392.
10. Via CS, Rus V, Nguyen P, Linsley P, Gause WC. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J Immunol. 1996;157:4258-4267. (Pubitemid 126449341)
11. Tsai CH, Tsai HH, Yang YY, et al. The in vivo effects of cytokine modulation for Balb/C mice fed with Canavalia ensiformis seeds. J Biomed Lab Sci. 2000;12:31-34.
12. Lin SJ, Tsai JH, Tsai CH, et al. The in vivo effects of cytokine modulation for Balb/C mice given Canavalia ensiformis (L.) seeds with different heat treatment. Food Chem. 2005;91: 139-145.
13. Shen YC, Chou CJ, Chiou WF, Chen CF. Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol. 2001;60:1083-1090.
14. Onai N, Tsunokawa Y, Suda M, et al. Inhibitory effects of bisbenzylisoquinoline alkaloids on induction of proinflammatory cytokines, interleukin-1 and tumor necrosis factor-α. Planta Med. 1995;61:497-501.
15. Chang DM, Chang WY, Kuo SY, Chang ML. The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol. 1997;24:436-441.
16. Mahady GB, Gyllenhall C, Fong HH, Farnsworth NR. Ginsengs: a review of safety and efficacy. Nutr Clin Care. 2000;3:90-101.
17. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol. 1999;55:567-575. (Pubitemid 29489202)
18. Lee SM, Li ML, Tse YC, et al. Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci. 2002;71: 2267-2277. (Pubitemid 35246215)
19. Matsuoka K, Isowa N, Yoshimura T, Liu M, Wada H. Green tea polyphenol blocks H2O2-induced interleukin-8 production from human alveolar epithelial cells. Cytokine. 2002;18:266-273. (Pubitemid 35007487)
20. Craig WJ. Health-promoting properties of common herbs. Am J Clin Nutr. 1999;70:491S-499S. (Pubitemid 29407127)
21. Huang L, Liu J, Li D, et al. A study on components and compound prescription of huangqin decoction. Zhongguo Zhong Yao Za Zhi. 1991:16:177-181.
22. Ferrante A, Seow WK, Rowan-Kelly B, Thong YH. Tetrandrine, a plant alkaloid, inhibits the production of tumour necrosis factor-α (cachectin) by human monocytes. Clin Exp Immunol. 1990;80:232-235. (Pubitemid 20147721)
23. Son CG, Han SH, Cho JH, et al. Induction of hemopoiesis by Saenghyuldan, a mixture of Ginseng Radix, Paeoniae Radix Alba, and Hominis Placenta extracts. Acta Pharmacol Sin. 2003;24:120-126.
24. Lin SJ, Tsai JH, Tsai CH, et al. The in vivo effects of cytokines modulation for BALB/C mice fed with a traditional combined Chinese herb-soaked solution, Yi-Fey Ruenn-Hou Tea. Immunopharmacol Immunotoxicol. 2004;26:435-444.
25. Wu MH, Tsai WJ, Don MJ, Chen YC, Chen IS, Kuo YC. Tanshinlactone A from Salvia miltiorrhiza modulates interleukin-2 and interferon-γ gene expression. J Ethnopharmacol. 2007;113:210-217. (Pubitemid 47243782)
26. Kim MS, Chung HS, Lee JG, et al. Inhibition of cytokine production by the traditional oriental medicine, Gamcho- Sasim-Tang in mitogen-stimulated peripheral blood mononuclear cells from Adamantiades-Behçets patients. J Ethnopharmacol. 2002;83:123-128.
27. Niizawa A, Kogure T, Hai LX, et al. Clinical and immunomodulatory effects of fun-boi, an herbal medicine, on collagen-induced arthritis in vivo. Clin Exp Rheumatol. 2003;21:57-62. (Pubitemid 36267532)
28. Wu RT, Lin WJ, Chiang HC, Horng LY, Chung YM. Modulation of experimental autoimmune uveitis with formosanin-C in guinea pigs. J Ocul Pharmacol. 1990;6:301-311.
29. Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I, Raisuddin S. Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol. 2003;3:257-265. (Pubitemid 36183384)
30. Guo FC, Kwakkel RP, Williams BA, et al. Effects of mushroom and herb polysaccharides on cellular and humoral immune responses of Eimeria tenella-infected chickens. Poult Sci. 2004;83:1124-1132. (Pubitemid 39197151)
31. Sakurai MH, Matsumoto T, Kiyohara H, Yamada H. B-cell proliferation activity of pectic polysaccharide from a medicinal herb, the roots of Bupleurum falcatum L. and its structural requirement. Immunology. 1999;97:540-547. (Pubitemid 29314654)
32. Tawfik AF, Bishop SJ, Ayalp A, el-Feraly FS. Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice. Int J Immunopharmacol. 1990;12: 385-389. (Pubitemid 20203629)
33. Asano K, Matsuishi J, Yu Y, Kasahara T, Hisamitsu T. Suppressive effects of Tripterygium wilfordii Hook f., a traditional Chinese medicine, on collagen arthritis in mice. Immunopharmacology. 1998;39:117-126. (Pubitemid 28321512)
34. ODell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine or a combination of all three medications. N Engl J Med. 1996;334:1287-1291. (Pubitemid 26138009)
35. Mottonen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet. 1999;353:1568-1573. (Pubitemid 29219206)
36. Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum. 2002;46:347-356. (Pubitemid 34136571)
37. Zhu YN, Zhao WM, Yang YF, et al. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo. J Pharmacol Exp Ther. 2006; 316:662-669.
38. Feng YX, Chen H. Pharmacognostic and chemical identification of Fang Ji (Stephania tetrandra). Yao Wu Fen Xi Za Zhi. 1985;5: 28-31.
39. Li QL, Xu YH, Zhon ZH, et al. The therapeutic effect of tetrandrine on silicosis. Zhonghua Jie He He Hu Xi Za Zhi. 1981;4:321-323.
40. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 1997;88:347-354. (Pubitemid 27131376)
41. Nagata S. Apoptosis by death factor. Cell. 1997;88:355-365. (Pubitemid 27131377)
42. Eguchi K. Apoptosis in autoimmune diseases. Intern Med. 2001;40:275-284. (Pubitemid 33606170)
43. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999;6:6-12. (Pubitemid 29051849)
44. Levine JS, Koh JS. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant. Semin Nephrol. 1999;19: 34-47. (Pubitemid 29048844)
45. Rovere P, Sabbadini MG, Fazzini F, et al. Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum. 2000;43: 1663-1672. (Pubitemid 30640921)
46. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 1994;37:1415-1420. (Pubitemid 24337682)
47. Hunig T, Schimpl A. Systemic autoimmune disease as a consequence of defective lymphocyte death. Curr Opin Immunol. 1997;9:826-830. (Pubitemid 28062267)
48. Ohsako S, Elkon KB. Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis. Cell Death Differ. 1999;6:13-21. (Pubitemid 29051850)
49. Wang Y. Effect of Shen-Mai against the apoptosis of peritoneal macrophage induced by lipopolysaccharide in mice. China J Med. 2001;1:35-41.
50. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62:3868-3875. (Pubitemid 34728874)
51. Ho LJ, Chang DM, Chang ML, Kuo SY, Lai JH. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J Rheumatol. 1999;26:14-24.
52. Zhou ZW, Liu PX. Progress in study of chemical constituents and anti-tumor activities of Cnidium monnieri. Zhongguo Zhong Yao Za Zhi. 2005;30:1309-1313.
53. Lin SJ, Chen CS, Lin SS, et al. In vitro anti-microbial and in vivo cytokines modulation effects of different prepared Chinese herbal medicines. Food Chem Toxicol. 2006;44:2078-2085.
54. Jeddar A, Kharsany A, Ramsaroop UG, Bhamjee A, Haffejee IE, Moosa A. The antibacterial action of honey: an in vitro study. S Afr Med J. 1985;67:257-258. (Pubitemid 15148952)
55. Hladó B, Bylka W, Ellnain-Wojtaszek M, et al. In vitro studies on the cytostatic activity of propolis extracts. Arzneimittelforschung. 1980;30:1847-1848. (Pubitemid 11240985)
56. Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta. 1984;792:92-97. (Pubitemid 14180908)
57. Grunberger D, Banerjee R, Eisinger K, et al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia. 1988;44:230-232. (Pubitemid 18066629)
58. Lee YJ, Liao PH, Chen WK, Yang CY. Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett. 2000;153:51-56.
59. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci U S A. 1996;93:9090-9095. (Pubitemid 26282023)
60. Su ZZ, Grunberger D, Fisher PB. Suppression of adenovirus type 5 EIA-mediated transformation and expression of the transformed phenotype by caffeic acid phenethyl ester (CAPE). Mol Carcinogen. 1991;4:231-242.
61. Jaiswal AK, Venugopal R, Mucha J, Carothers AM, Grunberger D. Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H: quinone oxidoreductase (NQ01) gene. Cancer Res. 1997;57: 440-446. (Pubitemid 27081661)
62. Cardile V, Panico A, Gentile B, Borrelli F, Russo A. Effect of propolis on human cartilage and chondrocytes. Life Sci. 2003;73:1027-1035. (Pubitemid 36734819)
63. Ho CC, Lin SS, Chou MY, et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J Antimicrob Chemother. 2005;56:372-379.
64. Sarker SD, Kumarasamy Y, Celik S, et al. Antibacterial and antioxidant activities of three Turkish species of the genus. Orient Pharm Exp Med. 2005;5:246-250.
65. Cao ZF. Scavenging effect of tetrandrine of active oxygen radicals. Planta Med. 1996;62:413-414.
66. Shi X, Mao Y, Saffiotti U, et al. Antioxidant activity of tetrandrine and its inhibition of quartz-induced lipid peroxidation. J Toxicol Environ Health. 1995;46:233-248.
67. Seow WK, Ferrante A, Li SY, Thong YH. Antiphagocytic and antioxidant properties of plant alkaloid tetrandrine. Int Arch Allergy Appl Immunol. 1988;85:404-409.
68. Kondo Y, Takano F, Hojo H. Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages. Biochem Pharmacol. 1993;46:1887-1892. (Pubitemid 23361893)
69. Kitts D, Hu C. Efficacy and safety of ginseng. Public Health Nutr. 2000;3:473-485. (Pubitemid 32095585)
70. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi. 2000;120:849-862.
71. Singh R, Ahmed S, Malemud CJ, Goldberg VM, Haqqi TM. Epigallocatechin-3- gallate selectively inhibits interleukin-1β- induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res. 2003;21:102-109. (Pubitemid 36157626)
72. Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H, Labadie RP. Inhibition of human complement by β-glycyrrhetinic acid. Immunology. 1997;90:115-120. (Pubitemid 27008398)
73. Tomoda M, Matsumoto K, Shimizu N, Gonda R, Ohara N, Hirabayashi K. An acidic polysaccharide with immunological activities from the root of Paeonia lactiflora. Biol Pharm Bull. 1994;17:1161-1164. (Pubitemid 24316184)
74. Friedl R, Moeslinger T, Kopp B, Spieckermann PG. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br J Pharmacol. 2001;134: 1663-1667.
75. Druey KM. Regulators of G protein signalling: potential targets for treatment of allergic inflammatory diseases such as asthma. Expert Opin Ther Targets. 2003;7:475-484. (Pubitemid 37063335)
76. Lombardi MS, Kavelaars A, Cobelens PM, et al. Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol. 2001;166:1635-1640. (Pubitemid 32114644)
77. Cooke PS, Selvaraj V, Yellayi S. Genistein, estrogen receptors, and the acquired immune response. J Nutr. 2006;136:704-708. (Pubitemid 43363758)
78. Gombart AF, Luong QT, Koeffler HP. Vitamin D compounds: activity against microbes and cancer. Anticancer Res. 2006;26: 2531-2542. (Pubitemid 44155532)
79. Purandare AV, Somerville JE. Antagonists of CCR4 as immunomodulatory agents. Curr Top Med Chem. 2006;6:1335-1344. (Pubitemid 44144919)
80. Lenert PS. Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res Ther. 2006;8:203-211.
81. Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol. 2006;533:69-76. (Pubitemid 43340005)
82. Fraser CC. Exploring the positive and negative consequences of NF-κB inhibition for the treatment of human disease. Cell Cycle. 2006;5:1160-1163. (Pubitemid 43845374)
83. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002;25:323-344. (Pubitemid 34634271)
84. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. Johns Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136:42-53. (Pubitemid 34038696)
85. Stavro PM, Woo M, Leiter LA, Heim TF, Sievenpiper JL, Vuksan V. Long-term intake of North American ginseng has no effect on 24-hour blood pressure and renal function. Hypertension. 2006;47:791-796. (Pubitemid 43740253)
86. Cheng TO. Ginseng and other herbal medicines that interact with warfarin. Int J Cardiol. 2005;104:227. (Pubitemid 41316994)
87. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol. 1999;55:567-575. (Pubitemid 29489202)
88. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol. 1998; 27:359-364.
89. Brinker FJ. Herb contraindications and drug interactions: with extensive appendices addressing specific conditions, herb effects, critical medications, and nutritional supplements. 2001; 3rd ed Sandy, Ore.: Eclectic Medical Publications.
90. Mok DKW, Chau FT. Chemical information of Chinese medicines: A challenge to chemist. Chemometrics Intell Lab Syst. 2006;82:210-217.
91. Johnson LP. Pocket guide to herbal remedies. 2002; Blackwell Science, Malden, Mass.
92. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine. 2002;9:1-33. (Pubitemid 41623448)